These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10404877)

  • 21. Who Expert Committee on Biological Standardization.
    World Health Organization
    World Health Organ Tech Rep Ser; 2004; 926():1-109. PubMed ID: 15918537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Status of WHO concerning continuous cell lines as substrates for the production of biologicals.
    Grachev V; Magrath D
    Dev Biol Stand; 1989; 70():215-9. PubMed ID: 2759349
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety issues of animal products used in serum-free media.
    Merten OW
    Dev Biol Stand; 1999; 99():167-80. PubMed ID: 10404888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current experience with biological products produced in various continuous cell lines. Summary and conclusions.
    Papermaster BW
    Dev Biol Stand; 1989; 70():227-9. PubMed ID: 2759350
    [No Abstract]   [Full Text] [Related]  

  • 25. The development, benefits and disadvantages of serum-free media.
    Froud SJ
    Dev Biol Stand; 1999; 99():157-66. PubMed ID: 10404887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing issues of quality control: diploid and non-diploid cell lines.
    Pearson J
    Dev Biol Stand; 1992; 76():13-7. PubMed ID: 1478333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Issues of biological assays for viral vaccines.
    Lee CK
    Dev Biol Stand; 1996; 88():41-7. PubMed ID: 9119161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Points to consider on virus safe plasma products.
    Biologicals; 1995 Jun; 23(2):193-5. PubMed ID: 7546664
    [No Abstract]   [Full Text] [Related]  

  • 29. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals (requirements for biological substances No 50).
    Dev Biol Stand; 1998; 93():141-71. PubMed ID: 9737395
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaccine cell substrates: bovine and porcine virus considerations.
    Wessman SJ
    Dev Biol (Basel); 2006; 123():273-80; discussion 291-308. PubMed ID: 16566453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality assurance for cell substrates.
    Stacey GN; Phillips P
    Dev Biol Stand; 1999; 98():141-51; discussion 167. PubMed ID: 10494967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WHO Expert Committee on Biological Standardization.
    Horowitz B; Minor P; Morgenthaler JJ; Burnouf T; McIntosh R; Padilla A; Thorpe R; van Aken WG;
    World Health Organ Tech Rep Ser; 2004; 924():1-232, backcover. PubMed ID: 15693660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of cell culture media components.
    Stacey G
    Hum Fertil (Camb); 2004 Jun; 7(2):113-8. PubMed ID: 15223760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Correlation of tests for control of contaminants, biochemistry and effectiveness of calf seru to be used for growth media for cell cultures].
    Voiculescu C; Schöffend L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1978; 23(1):47-54. PubMed ID: 565945
    [No Abstract]   [Full Text] [Related]  

  • 35. An animal origin perspective of common constituents of serum-free medium formulations.
    Jayme DW
    Dev Biol Stand; 1999; 99():181-7. PubMed ID: 10404889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An overview of quantitative PCR assays for biologicals: quality and safety evaluation.
    Xu Y; Brorson K
    Dev Biol (Basel); 2003; 113():89-98. PubMed ID: 14620857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review: production, characterization, and testing of banked mammalian cell substrates used to produce biological products.
    Schiff LJ
    In Vitro Cell Dev Biol Anim; 2005; 41(3-4):65-70. PubMed ID: 16029074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Laboratory for the control of serum vaccines and other biological products].
    M'Henni A
    Arch Inst Pasteur Tunis; 1997; 74(1-2):129-33. PubMed ID: 15945193
    [No Abstract]   [Full Text] [Related]  

  • 39. Basis for sample size in international conference on harmonization guidances.
    Lubiniecki A
    Dev Biol (Basel); 2006; 123():201-5; discussion 217-22. PubMed ID: 16566446
    [No Abstract]   [Full Text] [Related]  

  • 40. Reproducibility: Respect your cells!
    Baker M
    Nature; 2016 Sep; 537(7620):433-5. PubMed ID: 27629646
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.